SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001113423-16-000039
Filing Date
2016-03-30
Accepted
2016-03-29 19:58:40
Documents
14
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F aezs20-f2015.htm 20-F 4184604
2 EXHIBIT 4.7 exhibit47amendmentno2ksant.htm EX-4.7 12677
3 EXHIBIT 4.8 exhibit48kstransitionagree.htm EX-4.8 16835
4 EXHIBIT 8.1 exhibit81-20xfx2015.htm EX-8.1 19972
5 EXHIBIT 12.1 exhibit121-20xfx2015.htm EX-12.1 12204
6 EXHIBIT 12.2 exhibit122-20xfx2015.htm EX-12.2 12457
7 EXHIBIT 13.1 exhibit131-20xfx2015.htm EX-13.1 8007
8 EXHIBIT 13.2 exhibit132-20xfx2015.htm EX-13.2 7416
9 EXHIBIT 15.1 exhibit151-20xfx2015.htm EX-15.1 5685
10 capture.jpg GRAPHIC 69968
11 doddsig.jpg GRAPHIC 16699
12 kstransitionagreement_image1.jpg GRAPHIC 91117
13 signatpwcfs.jpg GRAPHIC 7895
14 tumora01.jpg GRAPHIC 48993
  Complete submission text file 0001113423-16-000039.txt   4593924
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30752 | Film No.: 161536751
SIC: 2834 Pharmaceutical Preparations